IDNA Holdings — iShares Genomics Immunology and Healthcare ETF
All 63 reported holdings of iShares Genomics Immunology and Healthcare ETF (IDNA) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 20.98% | $33.67M |
| Revolution Medicines, Inc. | 6.85% | $11.00M |
| Moderna, Inc. | 6.28% | $10.08M |
| Ipsen SA | 5.24% | $8.41M |
| Bayer Aktiengesellschaft | 4.38% | $7.03M |
| Takeda Pharmaceutical Company Limited | 4.22% | $6.77M |
| Merck & Co., Inc. | 4.15% | $6.66M |
| Gsk PLC | 4.12% | $6.62M |
| BioNTech SE | 4.07% | $6.53M |
| Roche Holding AG | 3.99% | $6.41M |
| Exelixis, Inc. | 3.80% | $6.09M |
| Twist Bioscience Corp | 3.79% | $6.08M |
| Regeneron Pharmaceuticals, Inc. | 3.73% | $5.98M |
| Sanofi SA | 3.58% | $5.75M |
| Vertex Pharmaceuticals Incorporated | 3.55% | $5.70M |
| Incyte Corporation | 3.52% | $5.65M |
| Genmab A/s | 3.16% | $5.08M |
| IDEAYA Biosciences Inc | 2.71% | $4.35M |
| Immunitybio Inc | 2.61% | $4.19M |
| Caris Life Sciences, Inc. | 2.44% | $3.91M |
| Arcus Biosciences, Inc. | 2.12% | $3.41M |
| Ono Pharmaceutical Co., Ltd. | 1.86% | $2.99M |
| CRISPR Therapeutics AG | 1.80% | $2.90M |
| Novavax, Inc. | 1.31% | $2.10M |
| Iovance Biotherapeutics Inc | 1.24% | $2.00M |
| GenFleet Therapeutics (Shanghai) Inc | 1.20% | $1.92M |
| Nuvation Bio Inc | 1.18% | $1.90M |
| Vir Biotechnology Inc | 1.07% | $1.71M |
| Abcellera Biologics Inc. | 1.06% | $1.71M |
| Corvus Pharmaceuticals Inc | 0.97% | $1.55M |
| Janux Therapeutics Inc | 0.86% | $1.38M |
| Kura Oncology Inc | 0.83% | $1.33M |
| Sunshine Lake Pharma Co Ltd | 0.62% | $1.00M |
| CytomX Therapeutics Inc | 0.60% | $962.32K |
| Ocugen Inc | 0.59% | $949.23K |
| Rigel Pharmaceuticals, Inc. | 0.57% | $910.73K |
| AbClon Inc. | 0.56% | $903.67K |
| Intellia Therapeutics, Inc. | 0.56% | $897.67K |
| Shanghai Henlius Biotech Inc | 0.50% | $805.58K |
| Pacific Biosciences Of California, Inc. | 0.48% | $768.01K |
| Design Therapeutics Inc | 0.47% | $758.35K |
| Valneva SE | 0.44% | $705.40K |
| Ginkgo Bioworks Holdings Inc | 0.40% | $636.98K |
| Verastem, Inc. | 0.40% | $634.87K |
| Alvotech SA | 0.39% | $629.19K |
| Personalis Inc | 0.33% | $522.58K |
| Xencor Inc | 0.30% | $484.88K |
| Guangzhou Innogen Pharmaceutical Group Co Ltd | 0.13% | $214.85K |
| Prime Medicine Inc | 0.13% | $201.52K |
| Euro | 0.04% | $65.62K |
| Mereo BioPharma Group PLC | 0.04% | $62.44K |
| Great British Pound | 0.01% | $11.49K |
| Swiss Franc | 0.00% | $7.02K |
| Danish Kroner | 0.00% | $5.90K |
| Arcellx, Inc. Cvr | 0.00% | $5.11K |
| Xav Health Care Jun26 | 0.00% | $1.13K |
| Japanese Yen | 0.00% | $171 |
| Korean Won | 0.00% | $126 |
| New Taiwan Dollar | 0.00% | $165 |
| Hong Kong Dollar | 0.00% | $167 |
| Omniab, Inc. | 0.00% | $0 |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 0.00% | $1 |
| Omniab, Inc. | 0.00% | $0 |
IDNA overview: performance, fees, allocation and SEC filings